Explore how low bioburden powders for terminal sterilization support sterile drug development, improve contamination control, ...
On May 26, 2020, the U.S. Food and Drug Administration (“FDA” or “Agency”) issued an immediately in effect guidance, Recommendations for Sponsors Requesting EUAs for Decontamination and Bioburden ...
As biopharma companies fine-tune their strategies for continuous bioprocessing, bioburden control has become a top priority. The approaches that worked for batch processing are inadequate for ...
Bioburden Testing Market · GlobeNewswire Inc. Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Bioburden Testing Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's ...
Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of ...
Another driver contributing to the market growth is the growing emphasis on regulatory compliance. Regulatory authorities across the globe are imposing strict guidelines and regulations regarding ...
The Global Bioburden Testing Market has experienced consistent growth, with a compound annual growth rate (CAGR) of 12-15%. This growth is driven by tightening regulatory standards and an increasing ...
In a recent press release, Tru-D announced a study published in the American Journal of Infection Control, Ultraviolet-C light as a means of disinfection anesthesia workstations, which demonstrated ...
The Global Bioburden Testing Market has been growing steadily at a CAGR of 12-15% due to increasing regulatory requirements and the rising focus on product safety. The market size is influenced by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results